Estíbaliz Miranda
-
- Acute Myeloid Leukemia Research 4
-
- Epigenetics and DNA Methylation 5
- Histone Deacetylase Inhibitors Research 5
- Protein Degradation and Inhibitors 4
- CRISPR and Genetic Engineering 2
- Pluripotent Stem Cells Research 1
- Single-cell and spatial transcriptomics 1
-
- Acute Lymphoblastic Leukemia research 3
Estíbaliz Miranda
16 papers receiving 227 citations
Peers
Comparison fields: 5 of 55
- Hematology 50
- Molecular Biology 191
- Public Health, Environmental and Occupational Health 43
- Cancer Research 21
- Genetics 13
Countries citing papers authored by Estíbaliz Miranda
This map shows the geographic impact of Estíbaliz Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estíbaliz Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estíbaliz Miranda more than expected).
Fields of papers citing papers by Estíbaliz Miranda
This network shows the impact of papers produced by Estíbaliz Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estíbaliz Miranda. The network helps show where Estíbaliz Miranda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Estíbaliz Miranda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 7 | |
| 3 | 2021 | 22 | |
| 4 | 2019 | 18 | |
| 5 | 2019 | 1 | |
| 6 | 2018 | 23 | |
| 7 | 2017 | 11 | |
| 8 | 2017 | 16 | |
| 9 | 2017 | 38 | |
| 10 | 2014 | 2 | |
| 11 | 2012 | 38 | |
| 12 | 2011 | 3 | |
| 13 | 2011 | 42 | |
| 14 | 2001 | 2 | |
| 15 | 2000 | 2 | |
| 16 | [Fanconi's anemia]. | 1999 | 6 |
| 17 | [WAGR syndrome: a case report]. | 1998 | 1 |
About Estíbaliz Miranda
Estíbaliz Miranda is a scholar working on Hematology, Molecular Biology and Genetics, having authored 17 papers that have together received 232 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Acute Myeloid Leukemia Research (4 papers), Protein Degradation and Inhibitors (4 papers), Acute Lymphoblastic Leukemia research (3 papers), CRISPR and Genetic Engineering (2 papers), Pluripotent Stem Cells Research (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Hematology (50 citations), Molecular Biology (191 citations) and Public Health, Environmental and Occupational Health (43 citations). Estíbaliz Miranda has collaborated with scholars based in Spain, China and Germany. Frequent co-authors include Xabier Agirre, Felipe Prósper, Leire Gárate, Edurne San José‐Eneriz, Amaia Vilas‐Zornoza, José I. Martı́n-Subero, J. Rifón, Iñigo Apaolaza, Marı́a José Calasanz and Francisco J. Planes. Their work appears in journals such as Nature Communications, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.